ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$239.62
−2.27%Forward multiples
Based on analyst estimates
- P/E forward
- 42.02x
- P/E 2026E
- 45.07x
- P/E 2027E
- 39.67x
- P/E 2028E
- 34.37x
- P/S forward
- 7.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 44.29x
- PEG TTM
- 8.26x
- Price / book
- 12.75x
- Price / sales
- 8.05x
- Price / cash flow
- 33.04x
Enterprise value
- Enterprise value
- $37.5B
- EV / sales
- 8.36x
- EV / EBITDA
- 27.54x
- EV / EBIT
- 39.85x
- Market cap
- $36.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026